體外膜氧合系統市場：按模式、按應用、按年齡組、按地區 - 規模、份額、前景、機會分析，2022-2030

體外膜肺氧合 (ECMO) 是一種在體外支持心肺功能的方法。根據引流和再灌注的位置，體外膜肺氧合系統分為動靜脈、靜脈-動脈和靜脈三種類型。它們還根據年齡分為新生兒、兒童和成人使用。 ECMO 通過套管引流和回輸端口的位置確定係統的模式。當引流和再灌注都來自中心靜脈時，稱為靜脈ECMO，當從靜脈到動脈時，稱為靜脈ECMO。 ECMO 對患有嚴重肺部或心髒病、等待心臟移植或從心臟移植中恢復的人很有用。當其他生命支持方式無效時，也可以使用它。 ECMO不能治癒疾病，但當組織不能提供足夠的氧氣時，它可以暫時幫助身體。

先天性心髒病發病率呈上升趨勢，ECMO的需求量越來越大。例如，根據美國心臟協會的數據，美國每年約有 40,000 名嬰兒出生時患有先天性心髒病，大約有 2 至 300 萬人患有先天性心髒病。

市場動態

ECMO 市場增長的推動因素包括心血管疾病和慢性呼吸道疾病（如哮喘、慢性阻塞性肺病 (COPD)、職業性肺病和肺動脈高壓）的患病率不斷上升。例如，根據世界衛生組織公佈的數據，到2022年5月，慢性阻塞性肺病（COPD）將成為全球第三大死因，2019年造成323萬人死亡。

本研究的主要特點

• 本報告對全球體外膜氧合器市場進行了深入分析，包括以 2021 年為基準年的預測期內（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。
• 解釋不同細分市場的潛在收入機會，並描述該市場具有吸引力的投資建議矩陣。
• 該研究還提供了有關市場驅動因素、抑制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 根據公司亮點、產品組合、關鍵亮點、財務業績和戰略等參數，對全球體外膜氧合系統市場的主要參與者進行簡介。
• 本研究涵蓋的主要公司包括 Medtronic、Getinge AB、LivaNova PLC、Terumo Corporation、XENIOS AG、OriGen Biomedical、EUROSETS NIPRO 和 MicroPort Scientific Corporation
• 本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球體外膜氧合系統市場報告包括投資者、供應商和產品
• 我們為該行業的各種利益相關者提供服務，包括製造商、分銷商、新進入者和財務分析師。
• 利益相關者應通過用於分析全球體外膜氧合系統市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 舉報內容
  • 市場定義和範圍
• 執行摘要
  • 按模式劃分的市場概況
  • 市場快照：按應用
  • 市場概況：按年齡組
  • 市場概況：按地區劃分
• 連貫的機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

• 市場動態
  • 驅動程序
  • 約束因素
  • 市場機會
• 影響分析
• 市場趨勢
• 技術進步
• PEST 分析
• 波特五力

第 4 章體外膜氧合系統全球市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 對供需的影響
• COVID-19 對市場的影響

第 5 章全球體外膜氧合器市場：按模式分類，2017-2030

• 動靜脈
• 靜脈動脈
• 靜脈

第 6 章全球體外膜氧合系統市場：按應用分類，2017-2030

• 體外心肺復蘇術
• 心
• 呼吸系統

第 7 章按年齡組分列的全球體外膜氧合器市場：2017-2030

• 新生兒
• 兒科
• 成人

第 8 章全球體外膜氧合器市場：按地區分列，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海合會
• 以色列
• 其他中東
• 非洲
• 北非
• 中非
• 南非

第 9 章競爭格局

• Medtronic
• Getinge AB
• LivaNova PLC
• Terumo Corporation
• XENIOS AG
• OriGen Biomedical
• EUROSETS
• NIPRO
• MicroPort Scientific Corporation

第 10 章

• 調查方法
• 關於出版商

Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are three different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial, and venovenous. Whereas, on the bases of age, ECMO systems are classified into neonatal, pediatric and adult. . The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. ECMO is helpful for people who are very ill with conditions of the lungs and heart, or who are awaiting for or recovering from a heart transplant. It may be used when other life support measures do not work. ECMO does not treat or cure a disease, but can assist the body temporarily when it is not able to provide the tissues with enough oxygen.

Growing number of congenital heart defects, increase demand for ECMO. For instance, according to American Heart Association, approximately 40,000 infants are born with a congenital heart defect in U.S. each year and around 2 to 3 million individuals are living with a congenital heart defect.

Market Dynamics

Growth of ECMO market is due to factors such as increasing prevalence of cardiovascular and chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, according to data published by the World Health Organization, in May 2022, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019.

Key features of the study:

• This report provides in-depth analysis of the global extracorporeal membrane oxygenation system market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global extracorporeal membrane oxygenation system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS NIPRO, and MicroPort Scientific Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global extracorporeal membrane oxygenation system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracorporeal membrane oxygenation system market

Detailed Segmentation:

• Global Extracorporeal Membrane Oxygenation System Market, By Modality:
  • Arteriovenous
  • Venoarteial
  • Venovenous
• Global Extracorporeal Membrane Oxygenation System Market, By Application:
  • Extracorporeal cardiopulmonary resuscitation
  • Cardiac
  • Respiratory
• Global Extracorporeal Membrane Oxygenation System Market, By Age Group:
  • Neonatal
  • Pediatric
  • Adults
• Global Extracorporeal Membrane Oxygenation System Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Medtronic
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Getinge AB
  • LivaNova PLC
  • Terumo Corporation
  • XENIOS AG
  • OriGen Biomedical
  • EUROSETS
  • NIPRO
  • MicroPort Scientific Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Modality
  • Market Snapshot, By Application
  • Market Snapshot, By Age Group
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Technological Advancements
• PEST Analysis
• PORTER'S Five Forces

4. Global Extracorporeal Membrane Oxygenation System Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Extracorporeal Membrane Oxygenation System Market, By Modality, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Arteriovenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Venoarteial
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Venovenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Extracorporeal Membrane Oxygenation System Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Extracorporeal cardiopulmonary resuscitation
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cardiac
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Respiratory
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Extracorporeal Membrane Oxygenation System Market, By Age Group, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Neonatal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Pediatric
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Adults
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Extracorporeal Membrane Oxygenation System Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• UK
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Getinge AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LivaNova PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• XENIOS AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OriGen Biomedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• EUROSETS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NIPRO
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• MicroPort Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us